Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

The management of acute myelogenous leukemia in elderly patients has been challenging and there has developed a pervasive pessimism about the role of chemotherapy in management. Two recent reports may counter this with demonstration of a benefit for induction chemotherapy and, in selected cases, both efficacy and safety of stem cell transplantation using nonmyeloablative conditioning.

Examining The Range of Therapy for Elderly Patients with Hematological Malignancy